Your session is about to expire
← Back to Search
Physical Activity Intervention for Prediabetes
Study Summary
This trial will examine how 8 weeks of moderate-intensity treadmill walking affects the gut microbiome, body weight, and cardiometabolic profile of overweight or obese people with prediabetes.
- Prediabetes
- Type 2 Diabetes
- Obesity
- Diabetes Mellitus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are considered overweight or obese based on your body mass index (BMI).You do less than 100 minutes of physical activity each week, as confirmed by a questionnaire.You have not taken any antibiotics in the last 45 days.Your weight has not changed by more than 10% in the last 6 months.You are taking metformin or other medications that might affect the main result of the study.You have been diagnosed with prediabetes based on specific blood test results from the past year or during the study screening.
- Group 1: Experimental Group
- Group 2: Control Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research accept participants of any age under forty?
"Individuals who are between 30 and 64 years of age may qualify for participation in this clinical trial."
Who is qualified to participate in this trial?
"This clinical trial is open to 100 participants aged 30-64 years old, who are classified as overweight or obese (BMI 25.0-39.9 kg/m2). To be eligible for enrollment, individuals must not have any exercise contraindications; they should also have been engaging in less than 100 minutes of physical activity per week and must maintain their current diet and exercise habits outside the study protocol changes. Furthermore, prospective patients cannot report any mental or physical disabilities, gastrointestinal conditions nor can they have taken antibiotics within the last 45 days. Lastly, participants need to show stable weight over the past 6 months (<10% change"
Are new participants being enrolled in this experiment presently?
"According to the clinicaltrials.gov website, this experiment is still recruiting subjects. It was initially announced on July 29th 2021 and most recently revised on March 9th 2022."
What aims does this research endeavor seek to fulfill?
"This 8-week clinical study is primarily aimed at examining serum short chain fatty acids (SCFA). Additionally, the researchers will be assessing the patients' levels of high density lipoprotein cholesterol (HDL-C) in milligrams per decilitre (mg/dl), fasting insulin in micro international units per millilitres (uIU/ml), and Hemoglobin A1C without any unit measure."
How many people have signed up to take part in this experiment?
"Affirmative. Clinicaltrials.gov indicates this clinical trial, initially posted on July 29th 2021, is actively recruiting participants. The team needs to recruit 100 patients at a single site for the study's completion."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger